The aim of this study is to evaluate the significance of immunohistochemical expression of
Galectin-3 in the differential diagnosis of benign and malignant
thyroid nodules. We studied the fine needle aspiration specimens of 38 patients who had evaluated for
nodular goiter and undergone a thyroid surgery between 2004-2005. Slides had been stained immunocytochemically with
Galectin-3. The cytoplasmic staining of
Galectin-3 was analyzed. Three cases of five follicular
carcinomas had positive staining for
Galectin-3, while two had not. Two cases with
follicular adenomas were negative for
Galectin-3. Five cases of six
papillary carcinomas had positive staining for
Galectin-3, while one case (the case with a papillary microcarcinoma) had not. The single cases with medullary and
anaplastic carcinomas were negative for
Galectin-3. None of the cases with a benign thyroid pathology had positive staining for
Galectin-3.
Galectin-3 immunocytochemical staining, had a sensitivity of 61.5%, specificity of 100%, positive predictive value of 100%, and negative predictive value of 83.3% for thyroid
malignancies. For the evaluation of follicular
neoplasm,
Galectin-3 immunocytochemical staining had a sensitivity of 60%, specificity of 100%, positive predictive value of 100%, and negative predictive value of 50%.
Galectin-3 expression in thyrocytes is a strong
indicator of a malignant proliferative lesion especially for papillary and to an extent in follicular
thyroid neoplasms.
Galectin-3 could be used as a supplementary marker for cytological diagnosis.